drugset / Trial / NCT00002662

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

NCT00002662 ↗

Phase 3 Completed Aventis Pharmaceuticals
RandomizedOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.

Timeline

Start
1994-08
Primary completion
—
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous
Subject Paclitaxel Small molecule — Intravenous

Indications